Back

Guideline-directed medical therapy presciption after acute heart failure hospitalization in Japan

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Multidisciplinary approach to heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Koshiro Kanaoka

National Cerebral & Cardiovascular Center, Suita (Japan)

6 More presentations in this session

Presentation thumbnail
New horizons in transthyretin cardiac amyloidosis therapy: A systematic review and meta-analysis of sodium-glucose cotransporter 2 inhibitors efficacy
Doctor M. Chacon Quiros (San Jose, CR)
Abstract Slides Video
Presentation thumbnail
Effects of early empagliflozin in acute decompensated HFrEF on ventricular systolic and diastolic parameters: interaction with endothelial function and arterial stiffness
Doctor O. Katsarou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Off-label low-dose therapy in heart failure reduced ejection fraction: can we achieve the benefits of the four pillars?
Doctor M. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Cardiovascular effects of preferred HOMe-based EXercise training and extended adherence measures in systolic heart failure
Doctor M. Bahls (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Innovative strategies and long-term outcomes in left ventricular assist devices therapy for advanced heart failure
Doctor N. Schaeffer (New York City, US)
Abstract Slides Video

Access the full session

Session thumbnail
Multidisciplinary approach to heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Outpatient prescribing of guideline-directed medical therapy in heart failure
thumbnail
Congress Presentation
Optimisation of timing and approach to implement guideline-directed medical therapy (GMDT) during admission
thumbnail
Congress Presentation
Trends in guideline-directed medical therapy and clinical outcomes in Taiwanese heart failure patients: insight from the TSOC HF registry 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources